Is it Time to Renew the Guidelines for Diagnosis of HIT ?

@inproceedings{Ahmadinejad2018IsIT,
  title={Is it Time to Renew the Guidelines for Diagnosis of HIT ?},
  author={Minoo Ahmadinejad},
  year={2018}
}
Since HIT is a clinicopathologic syndrome and considering the limitations of clinical scoring tools, the diagnosis of HIT is impossible without laboratory evidence of anti-PF4/heparin antibodies [1]. Based on a recent official recommendation of the Platelet Immunology SSC Working Group on HIT, “a diagnosis of HIT requires a clinical scenario in which HIT is judged to be the most plausible diagnosis, generally meeting at least an intermediate probability for HIT (judged by a clinical scoring… CONTINUE READING

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia”. Thrombosis and Haemostasis

L Sun
  • EC Cardiology
  • 2018

Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis

M Nagler
  • Blood 127.5
  • 2015

Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert® HIT) for the diagnosis of heparin-induced thrombocytopenia

D Leroux
  • British Journal of Haematology
  • 2014

Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and metaanalysis

A Cuker
  • Blood
  • 2012
VIEW 1 EXCERPT

Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings

GK Lo
  • Journal of Thrombosis and Haemostasis
  • 2006
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…